Home / People / MicrodoseCybin Granted U.S. Patent For CYB003 Psilocybin ProgramMicrodoseWed, Dec 6Cybin's new patent is expected to provide protection until 2041 and includes composition of matter claims for the company’s proprietary CYB003 novel psilocybin program. https://t.co/v0buQqhYBt5763New patent provides IP protection until at least 2041. Cybin’s patent portfolio now includes 39 granted patents and over 170 pending applications.Read More Discover MicrodoseNewsCannabisPsychedelicsAddictionDispensaryHealthOpioidsScience